Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McConnell

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Journal of the American College of Radiology : JACR|May 5, 2012
ACR Appropriateness Criteria(®) myelopathyDavid J Seidenwurm, Franz J Wippold, Rebecca S Cornelius, et al.
The British Journal of Dermatology|November 13, 2021
Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulcerationI Cosgarea, A T McConnell, T Ewen, et al.
Journal of the American College of Radiology : JACR|August 3, 2011
ACR Appropriateness Criteria® on cerebrovascular diseaseRobert L DeLaPaz, Franz J Wippold, Rebecca S Cornelius, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Physical Review Letters|August 11, 2023
First Dark Matter Search Results from the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, C W Akerlof, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Journal of the American College of Radiology : JACR|May 5, 2012
ACR Appropriateness Criteria(®) myelopathyDavid J Seidenwurm, Franz J Wippold, Rebecca S Cornelius, et al.
The British Journal of Dermatology|November 13, 2021
Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulcerationI Cosgarea, A T McConnell, T Ewen, et al.
Journal of the American College of Radiology : JACR|August 3, 2011
ACR Appropriateness Criteria® on cerebrovascular diseaseRobert L DeLaPaz, Franz J Wippold, Rebecca S Cornelius, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Physical Review Letters|August 11, 2023
First Dark Matter Search Results from the LUX-ZEPLIN (LZ) ExperimentJ Aalbers, D S Akerib, C W Akerlof, et al.
Pageof 7